Cargando…
Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma
PURPOSE: Hepatocellular carcinoma (HCC) is a common malignant tumor that seriously threatens human life and health. Currently, the majority of antitumor drugs are administered in an injectable manner, which can cause pain and side effects to patients. Objective of this study is to establish an effec...
Autores principales: | Ma, Chenjun, Wei, Tiantian, Hua, Yingying, Wang, Zhongjie, Zhang, Liefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259945/ https://www.ncbi.nlm.nih.gov/pubmed/34239301 http://dx.doi.org/10.2147/IJN.S315713 |
Ejemplares similares
-
Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation
por: Zhu, Zhi-feng, et al.
Publicado: (2008) -
A comparison of acyl-moieties for noncovalent functionalization of PLGA and PEG-PLGA nanoparticles with a cell-penetrating peptide
por: Paulino da Silva Filho, Omar, et al.
Publicado: (2021) -
Collagen/Chitosan Complexes: Preparation, Antioxidant Activity, Tyrosinase Inhibition Activity, and Melanin Synthesis
por: Hua, Yingying, et al.
Publicado: (2020) -
Docetaxel Loaded PEG-PLGA Nanoparticles: Optimized Drug Loading, In-vitro Cytotoxicity and In-vivo Antitumor Effect
por: Noori Koopaei, Mona, et al.
Publicado: (2014) -
Structural Optimization of Platinum Drugs to Improve the Drug-Loading and Antitumor Efficacy of PLGA Nanoparticles
por: Sokol, Maria B., et al.
Publicado: (2022)